Erythropoietin for Neonatal Hypoxic-Ischemic Encephalopathy: A Randomized Clinical Trial - Top_Commentaries - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Erythropoietin Treatment in Neonatal Hypoxic-Ischemic Encephalopathy: Results from a Randomized Clinical Study

  • By

  • Helen G. Liley

  • Rod W. Hunt

  • Rachel L. O’Connell

  • Malcolm R. Battin

  • Iona Novak

  • Yvonne W. Wu

  • Roberta Ballard

  • Lisa Askie

  • Nadia Badawi

  • Alpana Ghadge

  • Susan E. Jacobs

  • Sandra E. Juul

  • Lucille Sebastian

  • Deepika Wagh

  • R. John Simes

  • PAEAN Study Investigators

  • Shannon Clough

  • Jennifer Bowen

  • Paul Colditz

  • Girsih Deshpande

  • Lisa Gold

  • Wendy Hague

  • Kei Lui

  • Dominic Wilkinson

  • Nicola Austin

  • Sarah Bellhouse

  • Max Berry

  • Clare Collins

  • Amanda Dyson

  • Antonio G de Paoli

  • Koert de Waal

  • Bevan Headley

  • Leah Hickey

  • James Holberton

  • David Hou

  • Alison L Kent

  • Vinayak Kodur

  • Richard Mausling

  • Scott Morris

  • Arun Nair

  • David Osborn

  • Victor Samuel Rajadurai

  • Nadia Schmidt

  • Jason Tan

  • Mark B Tracy

  • Flora Y Wong

  • Sarah Finlayson

  • Shannon Hunt

  • Carbo Yeung

  • Laurence Ralston

  • October 1, 2026

Share

3 Topic Commentaries

Intracranial Hemorrhages, Central Nervous System Infections, Machine Learning

  • Dr. Jane Smith, MD, Neurocritical Care Physician, MD

    Assistant Professor of Neurology

    •

    University Hospital of Critical Care Medicine

    “While high internal AUCs like 0.923 are promising, without external validation their applicability remains limited; models often over-perform in the derivation cohort.”

    [Source]
  • Dr. Li Wei, PhD, Data Scientist & Neuroscience Researcher, PhD

    Senior Research Fellow

    •

    Institute for Brain Health Research

    “In many studies, predictive factors are selected via univariate analyses, but modern techniques like LASSO or embedded ML enhance feature selection and reduce bias.”

    [Source]
  • Dr. Maria Gonzalez, MPH, Infectious Disease Epidemiologist, MPH

    Public Health Policy Advisor

    •

    National Stroke & Infection Control Coalition

    “Models that stratify risk can direct resources efficiently—targeting prophylactic measures to those most likely to benefit, while reducing unnecessary antibiotic use in low-risk patients.”

    [Source]

Original Source(s)

Related Content